Sun Pharmaceutical Industries
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (67)
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Started: 11/19/2025
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Started: 11/29/2025
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Started: 8/5/2025
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Started: 10/19/2021
Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis
Started: 8/28/2015
Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis
Started: 9/4/2015
Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
Started: 3/1/2016
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
Started: 3/11/2016
Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis
Started: 8/1/2010
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Started: 8/1/2009
Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
Started: 8/1/2010
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Started: 8/1/2009
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Started: 4/4/2019
Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
Started: 3/21/2016
Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product
Started: 7/11/2016
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
Started: 8/1/2016
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis
Started: 8/28/2015
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis
Started: 9/4/2015
A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study
Started: 4/1/2015
Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS
Started: 7/11/2016
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression
Started: 9/2/2016
Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail
Started: 12/1/2014
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
Started: 9/1/2008
Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study
Started: 11/1/2009
Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study
Started: 2/1/2010
A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.
Started: 10/13/2025
A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris
Started: 8/4/2025
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
Started: 9/9/2019
A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris
Started: 6/20/2024
A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.
Started: 8/11/2023
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
Started: 5/13/2024
To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
Started: 7/1/2016
A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.
Started: 12/4/2023
A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris
Started: 2/22/2023
A Study Comparing Oxymetazoline 1% Cream to RHOFADE
Started: 2/23/2018
Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream
Started: 3/2/2018
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
Started: 3/20/2019
A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.
Started: 2/1/2013
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis
Started: 10/22/2018
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea
Started: 12/12/2017
Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis
Started: 6/27/2014
A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris
Started: 4/1/2015
A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%
Started: 3/20/2017
Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis
Started: 8/1/2013
Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris
Started: 11/1/2012
Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis
Started: 1/1/2012
Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris
Started: 9/1/2015
Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris
Started: 8/1/2014
Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris
Started: 10/1/2012
Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Started: 4/1/2014
A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris
Started: 1/1/2015
A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris
Started: 6/1/2014
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
Started: 8/8/2016
Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis
Started: 7/1/2010
Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis
Started: 5/1/2012
Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis
Started: 6/1/2008
A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris
Started: 9/1/2012
Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis
Started: 10/1/2008
Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.
Started: 1/1/2013
A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis
Started: 11/1/2011
A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis
Started: 10/1/2012
Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice
Started: 7/1/2009
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Started: 8/1/2011
Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis
Started: 1/23/2015